Clinical determinants of survival outcomes and acute toxicity after adoptive cellular therapy for solid tumors
BackgroundThe efficacy of cellular therapies has been demonstrated in hematologic malignancies, and their use is expanding to solid tumors. Predictors of outcomes and toxicities remain limited in patients undergoing cellular therapies for solid tumors….